Abstract
Elevated pretreatment serum interleukin-10 (IL-10) is associated with inferior progression-free survival (PFS) in patients with Hodgkin's disease (HD) treated with ABVD or equivalent regimens. Therefore, we explored the association of serum IL-10 with presenting features and PFS in HD patients treated only by radiotherapy (RT) with curative intent. Eligible patients were previously untreated, had biopsy-proven HD, were older than 16 years, HIV-negative, and had unthawed pretreatment serum. Serum IL-10 levels were measured with ELISA and were considered high if > or = 10 pg/ml. We identified 69 patients with median age of 34 years (range 16 - 74), of who 52% were males, and 3% had B-symptoms. Ann Arbor Stage was I in 35%, II in 58%, and III in 7% of the patients. Histology was lymphocyte predominance in 26%, and classical HD in 74% of the patients. Serum IL-10 was elevated in 35% of the patients. After a median follow-up of 67 months for survivors, the 5-year PFS of patients with high vs. normal serum IL-10 was 50% vs. 81% (all patients, P = 0.006), and 43% vs. 77% for the subset with classical HD (P = 0.008). Multivariate analysis revealed that high serum IL-10 and beta2-microglobulin were independently associated with inferior...Continue Reading
References
Apr 27, 1985·Lancet·J L HaybittleK A MacLennan
Jul 1, 1988·Clinical Radiology·E VergerA Horwich
Jun 1, 1988·American Journal of Clinical Oncology·E J HallN Oleinick
Jun 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R FarahR Weichselbaum
Oct 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A HorwichM J Peckham
May 1, 1985·Cancer·N T LeslieS Hellman
Feb 1, 1984·International Journal of Radiation Oncology, Biology, Physics·M TubianaE van der Schueren
Jul 4, 1995·International Journal of Cancer. Journal International Du Cancer·K OhshimaM Kikuchi
Dec 1, 1993·International Immunology·K TagaG Tosato
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A RuedaJ Miramón
Dec 31, 1997·Leukemia & Lymphoma·G J Ruiz-ArgüellesM G Apreza-Molina
Nov 20, 1998·The New England Journal of Medicine·D Hasenclever, V Diehl
Jun 17, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A H SarrisF Cabanillas
Feb 5, 2000·The Journal of Pathology·D F DukersC J Meijer
Mar 14, 2000·Medical Oncology·S VivianiG Bonadonna
Mar 18, 2000·Leukemia & Lymphoma·M K AngelopoulouG A Pangalis
May 10, 2000·Annals of Hematology·H BohlenH Tesch
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K H BackstrandP M Mauch
Jun 19, 2002·Blood·Danny F DukersJoost J Oudejans
Oct 24, 2002·Blood·Juan F GarcíaUNKNOWN Spanish Hodgkin Lymphoma Study Group
Nov 16, 2002·Blood·George Z RassidakisAndreas H Sarris
Citations
Dec 4, 2009·PloS One·Angélique GougeletClaudine Vermot-Desroches
Feb 18, 2016·British Journal of Cancer·Hua WangYue Lu
Sep 18, 2008·Leukemia & Lymphoma·Eric D Hsi
Apr 6, 2012·Leukemia & Lymphoma·Olav E YriHarald Holte
Apr 6, 2007·British Journal of Haematology·Je-Jung LeeYeon Hee Park
Aug 2, 2006·European Journal of Haematology·Carlo ViscoGiovanni Pizzolo
Jun 2, 2007·British Journal of Haematology·C TecchioM A Cassatella
Aug 4, 2011·PloS One·Alexandre KreissGregory M Woods
Oct 7, 2015·PloS One·Shuai ZhaoJian Huang
Mar 29, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·René-Olivier CasasnovasUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte
Jun 23, 2015·Immunology Letters·Maria Teresa P de AquinoAnil Shanker
Dec 29, 2007·The Journal of Pathology·C M Filippi, M G von Herrath
Oct 31, 2009·Scandinavian Journal of Immunology·E Bien, A Balcerska
Feb 7, 2019·Blood·Eric D HsiJonathan W Friedberg
Aug 18, 2020·Cancer Management and Research·Di WangJinming Yu
Aug 29, 2019·Vaccines·Taichiro Goto
Aug 18, 2018·Journal of Hematology & Oncology·Yang LiuJinming Yu
Dec 18, 2020·Cancers·Isacco FerrariniFabrizio Vinante
Nov 26, 2020·OncoTargets and Therapy·Jinjia ChangWenhua Li
Sep 23, 2021·Food & Function·Hatim BoughanemManuel Macias-Gonzalez